Ruth Greferath
No más puestos en curso
Perfil
Ruth Greferath is the founder of AC Immune SA, founded in 2003, and NormOxys, Inc., founded in 2004.
At NormOxys, Inc., she held the title of Biology Director from 2009 to 2011.
Dr. Greferath earned a doctorate degree from Yeshiva University.
Antiguos cargos conocidos de Ruth Greferath.
| Empresas | Cargo | Fin |
|---|---|---|
| AC IMMUNE SA | Fundador | - |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Fundador | - |
Formación de Ruth Greferath.
| Yeshiva University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| AC IMMUNE SA | Health Technology |
| Empresas privadas | 1 |
|---|---|
NormOxys, Inc.
NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Ruth Greferath
